To further substantiate the clinical relevance, immunohistochemical analysis was conducted on a separate cohort of 149 HBV-positive HCC patients (referred to as cohort 2), aiming to delineate the relationship between COLEC10 expression levels and clinicopathological characteristics (Figure 3d). Here, COLEC10 is linked to hepatocellular carcinoma.